Cinqair®
Cinqair® is a treatment for severe, uncontrolled eosinophilic asthma. whose asthma is not controlled with current asthma medicines and who have high levels of eosinophils. CINQAIR is the only anti-IL-5 with personalized weight-based dosing: Weight-based dosing enables your doctor to personalize a dose to you.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Teva Support Solutions® |
CLASS: Monoclonal Antibodies |
PRESCRIBED BY: Pulmonologists |
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Administered every four weeks. |
Length of infusion: 20 to 50 minutes plus an observation period of 30 minutes |
FOR MORE INFORMATION: |
